Celebrex Medication Labeling information

This section provides information on past and present label descriptions for the Celebrex medication.

These Celebrex medication labels include the pharmacological breakdown, chemical structure, warnings, indications, precautions, pharmcokinetics, and contraindications for the use of the Celebrex medication.

Pfizer submitted two seperate New Drug Applications (NDA's) to the FDA for it's Celebrex medication, so some of these documents are only for one or the other.

Both Celebrex Medication NDAs:

Questions and Answers Celebrex labeling change - warfarin interaction

Celebrex Labeling Changes June 7, 2002

Celebrex Medication NDA: 020998

Weitz & Luxenberg is no longer accepting Celebrex cases.

see also:

Label: 1/9/2004 Celebrex Labeling Description: 1/9/2004
Official FDA labeling description of Celebrex from January 9, 2004

NDA 020998: 10/18/2001 Celebrex Medicine Labels October 18, 2001
Celebrex medicine labels from October 18, 2001

Warnings Warnings of Celebrex Danger
The Following Letters Warn of the Danger of Celebrex.